Page 20 - 2020Taiwan Food and Drug Administration Annual Report
P. 20

4FDUJPO     'VUVSF 1FSTQFDUJWF
                  4FDUJPO


                       With the trends of global trade and the development of technology, the discovery of novel

                  substances and the impact of emerging technologies and new chemicals, the safety and sanitary
                  issues of food and medicinal products gradually become critical. In view of the importance of
                  food and drug safety and the expectations from the public, TFDA integrates different departments
                  and businesses, and expand the participation of the public to construct a safe protection network
                  for food, medical products, and cosmetics. Future important administrative plans include:
                  I.   Adopting the Forward-looking Infrastructure Development Program (infrastructure to
                      ensure food safety) to respond to future challenges, and execute 4 sub-programs, i.e. “The
                      construction plan of modern national food and drug laboratory and educational training
                      EXLOGLQJV ´ ³(I¿FLHQF\ LPSURYHPHQW SURJUDP WR H[SHGLWH ERUGHU LQVSHFWLRQ V\VWHP ´ ³3URJUDP

                      to strengthen health department’s food safety audition and inspection capacity,” and “Program
                      to strengthen central competent authority’s food safety, safe drug use and illegal drug
                      inspection capacity.”
                  II.  Implement “Five-Point Food Safety Policy” reform plan, continue to expand the food safety
                      management resources, combining business self-management and public participation to
                      maximize the effectiveness of limited resources by executing these management strategies,
                      the three-tier product quality management will be practically carry out, and the domestic food

                      management capacity will be enhanced.
                  III. Improve the comprehensiveness of regulatory environment, strengthen the control of drug
                      supply chain, and promote the regulation of the Management of Regenerative Medicinal
                      Products to ensure the safety of drug use for the citizens in Taiwan.
                  IV.  Actively promote the legislation of the Medical Device Act and announced the relevant sub-
                      regulations such as the Cosmetic Hygiene and Safety Act to meet the international standards,
                      enhance consumer protection, and facilitate the development of medical devices and cosmetics
                      industry.























            18
   15   16   17   18   19   20   21   22   23   24   25